The MRP Family and Anticancer Drug Metabolism

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|2|4|367-377

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.2, Iss.4, 2001-12, pp. : 367-377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs

By Phan Viet Hong   Tan Cindy   Rittau Anneliese   Xu Hongmei   McLachlan Andrew J   Clarke Stephen J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1395-1410

Informa Healthcare

Access to resources Recommend Favorite

The Metabolism of Anticancer Drugs by the Liver: Current Approaches to the Drug Development Process

By  

Current Drug Metabolism, Vol. 16, Iss. 7, 2015-09 ,pp. : 506-521

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Cytochrome P450 Activity in the Fate of Anticancer Agents and in Drug Resistance: Focus on Tamoxifen, Paclitaxel and Imatinib Metabolism

By Rochat Bertrand  

Clinical Pharmacokinetics, Vol. 44, Iss. 4, 2005-01 ,pp. : 349-366

Adis International

Access to resources Recommend Favorite

Anti-cancer Drug Development: Computational Strategies to Identify and Target Proteins Involved in Cancer Metabolism

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 532-577

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Cross-Talking Metabolism and Epigenetics in Anti-Cancer Drug Design)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 529-531

Bentham Science Publishers

Access to resources Recommend Favorite